In-office treatments are expensive, time-consuming, and realistically not something most of us can book as often as ...

According to Jin, the Medicube PDRN Pink Peptide Serum fits flawlessly into any routine. Apply it after your favorite ...

Social media thrives on transformation narratives, and skincare content is no exception. PDRN isn't totally snake oil, but is ...

Florida and Utah have banned fluoridation, with multiple other states looking to do the same. Critics of fluoride in drinking ...

Around this time of year, beauty brands tend to unleash their latest, buzziest products. Don’t forget, however, about one of ...

Pfizer Inc. (NYSE: PFE) today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, evaluating ...

Pfizer Inc. today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, ...

Johnson & Johnson today announced new longer follow-up results from the investigational Phase 1b/2 OrigAMI-1 study evaluating amivantamab-vmjw, a bispecific antibody targeting epidermal growth factor ...

RVMD stays a Strong Buy as RAS inhibitor trials advance; phase 3 RASolute-302 is a key 2026 catalyst. Read the latest ...

This case describes a woman in her mid-40s with recurrent colorectal cancer who developed severe dermatologic toxicity during ...

SAN FRANCISCO -- Including encorafenib (Braftovi) and cetuximab (Erbitux) in the first-line treatment of BRAF V600E-mutated ...

Accord BioPharma Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies, announced that Express Scripts, one of ...